Portfolio Manager Factsheet
Boston Scientific was volatile in the month given take-over speculation that saw the share price temporarily spike, overall momentum of the company and the share price continued in the month. Bluebird Bio presented updated data for a key pipeline asset in the treatment of beta thalassemia but was met with some selling pressure given high investor expectations. The position was added to on weakness.
Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.